Loading…
Loading…
EQUITY / OTC · PINX
Vsee Health Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.0502 USD
Observed: 09/23/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/23/2026 · 0.0502 USD · Volume 0
243 actual observations · Latest bar: 2026-09-23 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Revenue | 1,561,884 USD | — | — |
| Operating profit | -2,697,326 USD | — | — |
| Cash and cash equivalents | 454,151 USD | — | — |
| Total liabilities | 9,141,633 USD | — | — |
| Total equity | 7,592,775 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 203/31/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 101/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 454,151 USD | — | — | 1,346,132 USD | 5,051,445 USD | 5,266,286 USD | 472,759 USD | — |
| Gross profitIncome statement | 206,153 USD | 933,565 USD | — | 1,198,111 USD | — | 7,355,965 USD | 2,073,296 USD | 5,521,759 USD |
| Operating profitIncome statement | -2,697,326 USD | -4,356,859 USD | — | -2,974,275 USD | — | -9,582,893 USD | -2,057,521 USD | -6,143,579 USD |
| RevenueIncome statement | 1,561,884 USD | 3,441,177 USD | — | 3,160,185 USD | — | 14,618,184 USD | 3,980,655 USD | 10,692,259 USD |
| Total assetsBalance sheet | 16,734,408 USD | — | — | 19,016,419 USD | 22,413,019 USD | 22,413,019 USD | 18,707,122 USD | — |
| Total equityBalance sheet | 7,592,775 USD | — | 6,321,070 USD | 6,321,070 USD | 5,452,368 USD | 5,452,368 USD | -5,575,498 USD | — |
| Total liabilitiesBalance sheet | 9,141,633 USD | — | — | 12,695,349 USD | 16,960,651 USD | 16,960,651 USD | 24,282,620 USD | — |
| Capital expendituresCash flow statement | — | 100,000 USD | — | 26,752 USD | — | 29,928 USD | — | 22,776 USD |
| Financing cash flowCash flow statement | — | -842,626 USD | — | -1,341,211 USD | — | 8,415,832 USD | — | 1,689,052 USD |
| Investing cash flowCash flow statement | — | -128,752 USD | — | -126,752 USD | — | -29,928 USD | — | -22,776 USD |
| Net incomeIncome statement | — | -4,344,228 USD | — | -2,600,262 USD | — | -14,712,850 USD | -289,745 USD | -6,862,468 USD |
| Operating cash flowCash flow statement | — | -3,625,916 USD | — | -2,452,191 USD | — | -3,445,733 USD | — | -1,519,632 USD |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.